Published on Dec 14, 2020
KRAS Here we come !
 KRAS G12C inhibitor - Sotorasib
  • Approved for locally advanced or metastatic non–small cell lung cancer (NSCLC)
  • CodeBreaK 200 - study enrols patients with the above change
Terms and Conditions Privacy Refund Policy Learning Management System by Testpress